Advertisement

Current Dilemmas in the Management of Adults with Severe Community-Acquired Pneumonia

  • J. Rello
  • J. A. Paiva
  • C. S. Dias
Conference paper

Abstract

Severe community-acquired pneumonia (CAP) is generally regarded as pneumonia requiring a specific clinical approach in an intensive care unit (ICU) [1–15]. Between 10 and 36% of patients with CAP who are hospitalized need ICU treatment [3, 16, 17], and mortality ranges from 20 to 50% [5–11].

Keywords

Chronic Obstructive Pulmonary Disease Intensive Care Unit Admission Invasive Aspergillosis Respir Crit Pneumococcal Pneumonia 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Garibaldi RA (1985) Epidemiology of community-acquired respiratory tract infections in adults. Am J Med 78 (suppl 6B): 32–37PubMedCrossRefGoogle Scholar
  2. 2.
    Woodhead MA, Macfarlane JT, McCracken JS, Rose DH, Finch RG (1987) Prospective study of the aetiology and outcome of pneumonia in the community. Lancet 1: 671–674PubMedCrossRefGoogle Scholar
  3. 3.
    Ewig S, Torres A (1999) Severe community-acquired pneumonia. Clin Chest Med 20: 575–587PubMedCrossRefGoogle Scholar
  4. 4.
    Leeper KV, Torres A (1995) Community-acquired pneumonia in the intensive care unit. Clin Chest Med 16: 155–171PubMedGoogle Scholar
  5. 5.
    Woodhead MA, Mcfarlane JT, Rodgers FG, Laverick A, Pilkington R, Macrae AD (1985) Aetiology and outcome of severe community-acquired pneumonia. J Infect 10: 204–210PubMedCrossRefGoogle Scholar
  6. 6.
    Pachon J, Prado MD, Capote F, Cuello JA, Garnacho J, Verano A (1990) Severe community-acquired pneumonia. Am Rev Respir Dis 42: 369–373CrossRefGoogle Scholar
  7. 7.
    Torres A, Serra-Bailles J, Ferrer A, et al (1991) Severe community-acquired pneumonia. Epidemiology and prognostic factors. Am Rev Respir Dis 114: 312–318Google Scholar
  8. 8.
    British Thoracic Society Research Committee and the Public Health Laboratory Service (1992) The aetiology, management and outcome of severe community-acquired pneumonia on the intensive care unit. Respir Med 86: 7–13Google Scholar
  9. 9.
    Rello J, Quintana E, Ausina V, Net A, Prats G (1993) A three-year study of severe community-acquired pneumonia with emphasis on outcome. Chest 103: 232–235PubMedCrossRefGoogle Scholar
  10. 10.
    Moine P, Vercken JB, Chevret S, Chastang C, Gajdos P (1994) Severe community-acquired pneumonia. Etiology, epidemiology, and prognosis factors. Chest 105: 1487–1495Google Scholar
  11. 11.
    Leroy O, Santre C, Beuscart C, et al (1995) A 5-year study of severe community-acquired pneumonia with emphasis on prognosis in patients admitted to an intensive care unit. Intensive Care Med 21: 24–31PubMedCrossRefGoogle Scholar
  12. 12.
    Feldman C, Ross S, Mahomed AG, Omar J, Smith C (1995) The aetiology of severe community-acquired pneumonia and its impact on initial, empiric, antimicrobial treatment. Respir Med 89: 187–192PubMedCrossRefGoogle Scholar
  13. 13.
    Rello J, Rodriguez R, Jubert P, Alvarez B (1996) Severe community-acquired pneumonia in the elderly. Epidemiology and prognosis. Clin Infect Dis 23: 723–728Google Scholar
  14. 14.
    Hirani NA, Macfarlane IT (1997) Impact of management guidelines on the outcome of severe community-acquired pneumonia. Thorax 52: 17–21PubMedCrossRefGoogle Scholar
  15. 15.
    Ruiz M, Ewig S, Marcos MA, et al (1999) Etiology of community-acquired pneumonia. Am J Resp Crit Care Med 160: 397–405PubMedCrossRefGoogle Scholar
  16. 16.
    Marrie T J, Durant H, Yates L (1989) Community-acquired pneumonia requiring hospitalization: 5-year prospective study. Rev Infect Dis 11: 586–599PubMedCrossRefGoogle Scholar
  17. 17.
    Sörensen J, Forseberg P, Hakanson E, et al (1989) A new diagnostic approach to the patient with severe pneumonia. Scand J Infect Dis 21: 33–41PubMedCrossRefGoogle Scholar
  18. 18.
    Niederman MS, Bass J, Campbell GD, Torres A, Yu VL (1993) American Thoracic Society Guidelines for the initial management of adults with community-acquired pneumonia: diagnosis, assessment of severity and initial antimicrobial therapy. Am Rev Respir Dis 148: 1418–1426PubMedCrossRefGoogle Scholar
  19. 19.
    European Study on Community-acquired pneumonia (ESOCAP) Committee (1998) Guidelines for management of adult community-acquired lower respiratory tract infections. Eur Respir J 11: 986–991Google Scholar
  20. 20.
    Bartlett J G, Dowell SF, Mandell LA, File TM Jr, Musher DM, Fine MJ (2000) Practice guidelines for the management of commmunity-acquired pneumonia in adults. Guidelines from the Infectious Diseases Society of America. Clin Infect Dis 31: 347–382Google Scholar
  21. 21.
    Mandell LA, Marrie TJ, Grossman RF, Chow AUJ, Hyland RH (2000) Canadian guidelines for the initial management of community-acquired pneumonia: an evidence-based update by the Canadian Infectious Diseases Society and the Canadian Thoracic Society. Clin Infect Dis 31: 383–421PubMedCrossRefGoogle Scholar
  22. 22.
    American Thoracic Society (2001) ATS Guidelines for the management of adults with community-acquired pneumonia. Diagnosis, assessment of severity. Antimicrobial therapy and prevention. Am J Respir Crit Care Med 163: 1730–1754Google Scholar
  23. 23.
    SPILF, Societe de Pathologie Infectieuse de Langue Française (1991) Infections des voies respiratoires: conference de concensus en therapeutique anti-infectieuse. Rev Med Infect 21: 1s - 8sGoogle Scholar
  24. 24.
    Gialdroni GG, Bianchi L (1995) Guidelines for the management of community-acquired pneumonia in adults. Monaldi Arch Dis Chest 50: 21–27Google Scholar
  25. 25.
    SEPAR, Spanish Thoracic Society (1992) National Recommendations for Diagnosis and Treatment of Community Acquired Pneumonia. Ediciones Doyma, BarcelonaGoogle Scholar
  26. 26.
    British Thoracic Society (1993) Guidelines for the management of community-acquired pneumonia in adults admitted to hospital. Br J Hosp Med 49: 349–350Google Scholar
  27. 27.
    Huchon GJ, Gialdroni GG, Leophonte P, Manresa F, Schaberg T, Woodhead M (1996) Initial antibiotic therapy for lower respiratory tract infection in the community: a European survey. Eur Respir J 9: 1590–1595PubMedCrossRefGoogle Scholar
  28. 28.
    Ortqvist A (1995) Antibiotic treatment of community-acquired pneumonia in clinical practice: a European perspective. J Antimicrob Chemother 35: 205–212PubMedCrossRefGoogle Scholar
  29. 29.
    Nathwani D, Rubinstein E, Barlow G, Davey P (2001) Do guidelines for community-acquired pneumonia improve the cost-effectiveness of hospital care? Clin Infect Dis 32: 728741Google Scholar
  30. 30.
    Rello J, Paiva JA, Baraibar J, Rios M, Rodriguez A, Sole-Violan J (2001) International conference for the development of consensus on the diagnosis and treatment of ventilator-associated pneumonia. Chest 120: 955–970PubMedCrossRefGoogle Scholar
  31. 31.
    Fine MJ, Smith MA, Carson CA, et al (1996) Prognosis and outcomes of patients with community-acquired pneumonia. JAMA 275: 134–141PubMedCrossRefGoogle Scholar
  32. 32.
    Fine MJ, Auble TE, Yealy DM, et al (1997) A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med 336: 243–250PubMedCrossRefGoogle Scholar
  33. 33.
    Gilbert K, Fine MJ (1994) Assessing prognosis and predicting patients outcomes in community-acquired pneumonia. Semin Respir Infect 9: 140–152PubMedGoogle Scholar
  34. 34.
    Ruiz M, Ewig S, Torres A, et al (1999) Severe community-acquired pneumonia. Risk factors and follow-up epidemiology. Am J Respir Crit Care Med 160: 923–929Google Scholar
  35. 35.
    Ewig S, Schäfer H, Torres A (2000) Severity assessment in community-acquired pneumonia. Eur Respir J 16: 1193–1201PubMedCrossRefGoogle Scholar
  36. 36.
    Houston MS, Silverstein MD, Suman VJ (1997) Risk factors for 30-day mortality in elderly patients with lower respiratory tract infection: a community-based study. Arch Intern Med 157: 2190–2195PubMedCrossRefGoogle Scholar
  37. 37.
    British Thoracic Society and the Public Health Laboratory Service (1987) Community-acquired pneumonia in adults in British hospitals in 1982–1983: a survey of aetiology, mortality and prognostic factors and outcome. QJM 239: 195–120Google Scholar
  38. 38.
    Farr BM, Sloman AJ, Fisch MJ (1991) Predicting death in patients hospitalized for community-acquired pneumonia. Ann Intern Med 115: 428–436PubMedCrossRefGoogle Scholar
  39. 39.
    Karalus NC, Cursons RT, Leng RA, Coleman L (1991) Community-acquired pneumonia: aetiology and prognostic index evaluation. Thorax 46: 413–418PubMedCrossRefGoogle Scholar
  40. 40.
    Neil AM, Martin IR, Weir R, Frampton C, Hutton S, Chambers ST, Town GI (1996) Community-acquired pneumonia: aetiology and usefulness of severity criteria on admission. Thorax 51: 1010–1016CrossRefGoogle Scholar
  41. 41.
    Lim WS, Lewis S, Macfarlane JT (2000) Severity prediction rules in community-acquired pneumonia: a validation study. Thorax 55: 219–223PubMedCrossRefGoogle Scholar
  42. 42.
    Ewig S, Kleinfeld T, Bauer T, Seifert K, Schafer H, Goke N (1999) Comparative validation of prognostic rules for community acquired pneumonia in an elderly population. Eur Respir J 14: 370–375PubMedCrossRefGoogle Scholar
  43. 43.
    Conte HA, Chen YT, Mehal W, Scinto JD, Quagliarello VJ (1999) A prognostic rule for elderly patients admitted with community-acquired pneumonia. Am J Med 106: 20–28PubMedCrossRefGoogle Scholar
  44. 44.
    Woodhead M (1996) Predicting death from pneumonia. Thorax 51: 970–971PubMedCrossRefGoogle Scholar
  45. 45.
    Gordon G, Throop D, Berberian L (1996) Validation of the American Thoracic Society Guidelines for community-acquired pneumonia in hospitalized patients. Am J Respir Crit Care Med 153: A257 (abst)Google Scholar
  46. 46.
    Ewig S, Ruiz M, Mensa J, et al (1998) Severe community-acquired pneumonia-assessment of severity criteria. Am J Respir Crit Care Med 158: 1102–1108PubMedCrossRefGoogle Scholar
  47. 47.
    Leroy O, Devos P, Guery B, et al (1999) Simplified prediction rule for prognosis of patients with severe community-acquired pneumonia in ICUs. Chest 116: 157–165PubMedCrossRefGoogle Scholar
  48. 48.
    Dean NC (1999) Use of prognostic scoring and outcome assessment tools in the admission decision for the community-acquired pneumonia. Clin Chest Med 20: 521–529PubMedCrossRefGoogle Scholar
  49. 49.
    Almirall J, Mesalles E, Klamburg J, Parra O, Agudo A (1995) Prognostic factors of pneumonia requiring admission to the intensive care unit. Chest 107: 511–516PubMedCrossRefGoogle Scholar
  50. 50.
    Riquelme R, Torres A, El-Ebiary M, Hernandez C, Rodriguez-Roisin R (1996) Community-acquired pneumonia in the elderly: etiology, risk, and prognosis factors. Am J Respir Crit Care Med 154: 1450–1455PubMedCrossRefGoogle Scholar
  51. 51.
    Atlas SJ, Benzer TI, Borowsky LH, et al (1998) Safely increasing the proportion of patients with community-acquired pneumonia treated as outpatients: an interventional trial. Arch Intern Med 158: 1350–1356PubMedCrossRefGoogle Scholar
  52. 52.
    San Pedro GS, Campbell GD Jr (1997) Limitations of diagnostic testing in the initial management of patients with community-acquired pneumonia. Semin Respir Infect 12: 300–307Google Scholar
  53. 53.
    Gleckman R, Devita J, Hibert D, Pelletier C, Martin R (1988) Sputum Gram stain assessment in community-acquired bacteremic pneumonia. J Clin Microbiol 26: 846–849PubMedGoogle Scholar
  54. 54.
    Theerthakarai R, El-Halees W, Ismail M, Solis RA, Khan MA (2001) Non value of initial microbiological studies in the management of non severe community-acquired pneumonia. Chest 119: 181–184PubMedCrossRefGoogle Scholar
  55. 55.
    Benner EJ, Munzinger JP, Chan R (1974) Superinfections of the lung. An evaluation by serial transtracheal aspirate. West J Med 121: 173–178Google Scholar
  56. 56.
    Potgieter PD, Hammond JMJ (1992) Etiology and diagnosis of pneumonia requiring ICU admission. Chest 101: 199–203PubMedCrossRefGoogle Scholar
  57. 57.
    Rein MF, Gwaltney JM, O’Brien WM, Jennings RH, Mandell GL (1978) Accuracy of Gram’s stain in identifying pneumococci in sputum. JAMA 239: 2671–2673PubMedCrossRefGoogle Scholar
  58. 58.
    Thorsteinsson SB, Musher DM, Fagan T (1975) The diagnostic value of sputum culture in acute pneumonia. JAMA 233: 894–895PubMedCrossRefGoogle Scholar
  59. 59.
    Park DR, Skerrett SJ (1995) The usefulness of the sputum Gram stain in the diagnosis of pneumonia. Clin Pulm Med 2: 201–212CrossRefGoogle Scholar
  60. 60.
    Dans PE, Charache P, Fahey M (1996) Management of pneumonia in the prospective payment era. Arch Intern Med 144: 1392–1397CrossRefGoogle Scholar
  61. 61.
    Boerner DF, Zwadyk P (1982) The value of the sputum Gram’s stain in community-acquired pneumonia. JAMA 247: 642–645PubMedCrossRefGoogle Scholar
  62. 62.
    Ort S, Ryan JL, Barden G, D’Esopo N (1983) Pneumococcal pneumonia in hospitalized patients. JAMA 249: 214–248PubMedCrossRefGoogle Scholar
  63. 63.
    Ortqvist A, Jonsson I, Kalin M, Krook A (1989) Comparison of three methods for detection of pneumococcal antigen in sputum of patients with community-acquired pneumonia. Eur J Clin Microbiol Infect 8: 956–961CrossRefGoogle Scholar
  64. 64.
    Skerrett SJ (1999) Diagnostic testing for community-acquired pneumonia. Clin Chest Med Sept 20: 531–548CrossRefGoogle Scholar
  65. 65.
    Reed WW, Byrd GS, Gates RH Jr, Howard RS, Weaver MJ (1996) Sputum Gram’s stain in community-acquired pneumonia: a meta-analysis. West J Med 165: 197–204PubMedGoogle Scholar
  66. 66.
    Fine MJ, Orloff JJ, Rihs JD, et al (1991) Evaluation of housestaff physicians preparation and interpretation of sputum Gram stains for community-acquired pneumonia. J Gen Intern Med 6: 189–198PubMedCrossRefGoogle Scholar
  67. 67.
    Merill CW, Gwaltney JM, Hendley JO (1973) Rapid identification of pneumococci Gram stain vs the Quellung reaction. N Engl J Med 288: 510–512CrossRefGoogle Scholar
  68. 68.
    Perlino CA (1984) Laboratory diagnosis of pneumonia due to Streptococcus pneumonia. J Infect Dis 150: 139–144PubMedCrossRefGoogle Scholar
  69. 69.
    Kalin M, Lindberg AA (1983) Diagnosis of pneumococcal pneumonia. A comparison between microscopic examination of expectorate antigen detection and cultured procedures. Scand J Infect Dis 15: 247–255Google Scholar
  70. 70.
    Arbo MDJ, Snydman DR (1994) Influence of blood cultures results on antibiotic choice in treatment of bacteremia. Arch Intern Med 154: 2641–2645PubMedCrossRefGoogle Scholar
  71. 71.
    Waterer GW, Jenning SG, Wunderink RG (1999) The impact of blood cultures on antibiotic therapy in pneumococcal pneumonia. Chest 116: 1278–1281PubMedCrossRefGoogle Scholar
  72. 72.
    Bryan CS (1999) Blood cultures for community-acquired pneumonia. No place to skimp. Chest 116: 1153–1155PubMedCrossRefGoogle Scholar
  73. 73.
    Chalasani NP, Valdecanas MA, Gopal AK, McGowan JE Jr, Jurado RL (1995) Clinical utility of blood cultures in adult patients with CAP without defined underlying risks. Chest 108: 932–936PubMedCrossRefGoogle Scholar
  74. 74.
    Woodhead MA, Arrowsmith J, Chamberlain-Webber R, Wooding S, Williams I (1991) The value of routine microbial investigation in community-acquired pneumonia. Respir Med 85: 313–317PubMedCrossRefGoogle Scholar
  75. 75.
    Bartlett JG, Mundy LM (1995) Community-acquired pneumonia. N Engl J Med 333: 1618 1624Google Scholar
  76. 76.
    Marston BJ, Plouffe JF, File TM Jr, et al (1997) Incidence of community-acquired pneumonia requiring hospitalization: results of a population-based active surveillance study in Ohio. Arch Intern Med 157: 1709–1718PubMedCrossRefGoogle Scholar
  77. 77.
    Porath A, Schlaeffer F, Lieberman D (1997) The epidemiology of community-acquired pneumonia among hospitalized adults. J Infect 34: 41–48PubMedCrossRefGoogle Scholar
  78. 78.
    Fang GD, Fine M, Orloff J, et al (1990) New and emerging etiologies for community-acquired pneumonia with implications for therapy: a prospective multicenter study of 359 cases. Medicine 69: 307–316PubMedCrossRefGoogle Scholar
  79. 79.
    Mundy LM, Auwaerter PG, Oldach D, Gopalan R, Moore RD (1995) Community-acquired pneumonia: impact of immune status. Am J Respir Crit Care Med 152: 1309–1315PubMedCrossRefGoogle Scholar
  80. 80.
    Ewig S, Bauer T, Hasper E, Pizzulli L, Kubini R, Luderitz B (1996) Value of routine microbial investigation in community-acquired pneumonia treated in a tertiary care center. Respiration 63: 164–169PubMedCrossRefGoogle Scholar
  81. 81.
    Marrie TJ (1994) Community-acquired pneumonia. Clin Infect Dis 18: 501–513PubMedCrossRefGoogle Scholar
  82. 82.
    Moine P, Vercken JB, Chevret S, Gajdos P (1995) Severe community-acquired pneumococcal pneumonia. The French Study Group of Community-Acquired Pneumonia in ICU. Scand J Infect Dis 27: 201–206Google Scholar
  83. 83.
    Plouffe JF, Breiman RF, Facklam RR (1996) Bacteremia with Streptococcus pneumoniae: implications for therapy and prevention. JAMA 275: 194–198PubMedCrossRefGoogle Scholar
  84. 84.
    Lippmann ML, Goldberg SK, Walkenstein MD, Herring W, Gordon M (1995) Bacteremic pneumococcal pneumonia: a community hospital experience. Chest 108: 1608–1613PubMedCrossRefGoogle Scholar
  85. 85.
    Watanakunakorn C, Bailey TA (1997) Adult bacteremic pneumococcal pneumonia in a community teaching hospital, 1992–1996: a detailed analysis of 108 cases. Arch Intern Med 157: 1965–1975PubMedCrossRefGoogle Scholar
  86. 86.
    Souto JE, Yu VL (1997) Legionellosis. N Engl J Med 337: 682–687CrossRefGoogle Scholar
  87. 87.
    Marston BJ, Lipman HB, Breiman RF (1994) Surveillance for legionnaires’ disease: risk factors for morbidity and mortality. Arch Intern Med 154: 2417–2422PubMedCrossRefGoogle Scholar
  88. 88.
    Edelstein PH (1993) Legionnaires’s disease. Clin Infect Dis 16: 741–749PubMedCrossRefGoogle Scholar
  89. 89.
    Glanville AR, Marlin GE, Hartnett BJS (1995) The use of fiberoptic bronchoscopy with sterile catheter in the diagnosis of pneumonia. Aust NZ J Med 15: 309–319CrossRefGoogle Scholar
  90. 90.
    Wimberly NW, Bass JB Jr, Boyd BW, Kirkpatrick MB, Serio RA, Pollock HM (1982) Use of a bronchoscopic protected catheter brush in the diagnosis of pulmonary infections. Chest 81: 556–562CrossRefGoogle Scholar
  91. 91.
    Shelhamer JH, Gill VJ, Quinn TC, et al (1996) The laboratory evaluation of opportunistic pulmonary infections. Ann Intern Med 124: 585–599PubMedCrossRefGoogle Scholar
  92. 92.
    Feinsilver SH, Fein AM, Niederman MS, Schultz DE, Faegenburg DH (1990) Utility of fiber-optic bronchoscopy in non-resolving pneumonia. Chest 98: 1322–1326PubMedCrossRefGoogle Scholar
  93. 93.
    Pollock HM, Hawkins EL, Bonner JR, Sparkman T, Bass JB Jr (1983) Diagnosis of bacterial pulmonary infections with quantitative protected catheter cultures obtained during bronchoscopy. J Clin Microbiol 17: 255–259PubMedGoogle Scholar
  94. 94.
    Teague RB, Wallace RJ, Awe RJ (1981) The use of quantitative sterile brush culture and Gram stain analysis in the diagnosis of lower respiratory tract infection. Chest 79: 157–161PubMedCrossRefGoogle Scholar
  95. 95.
    Jimenez P, Saldias F, Meneses M, Silva ME, Wilson MG, Otth L (1993) Diagnostic fiberoptic bronchoscopy in patients with community-acquired pneumonia: comparison between bronchoalveolar lavage and telescoping plugged catheter cultures. Chest 103: 1023–1027PubMedCrossRefGoogle Scholar
  96. 96.
    Wald A, Leisenring W, van Burik JA, Bowden RA (1997) Epidemiology of Aspergillus infections in a large cohort of patients undergoing bone marrow transplantation. J Infect Dis 175: 1459–1466PubMedCrossRefGoogle Scholar
  97. 97.
    Heffelfinger JD, Dowell SF, Jorgensen JH, Schuchat A, Whitney CG (2000) Management of community-acquired pneumonia in the era of pneumococcal resistance: a report from the drug-resistant streptococcus pneumoniae therapeutic working group. Arch Intern Med 160: 1399–1408PubMedCrossRefGoogle Scholar
  98. 98.
    Gleason PP, Meehan TP, Fine JM, Galusha DH, Fine MJ (1999) Associations between antimicrobial therapy and medical outcomes for hospitalized elderly patients with pneumonia. Arch Intern Med 159: 2562–2572PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2003

Authors and Affiliations

  • J. Rello
  • J. A. Paiva
  • C. S. Dias

There are no affiliations available

Personalised recommendations